Jamil Khurram

Galectin Therapeutics Inc. · Chief Medical Officer

Jamil Khurram is listed in public filings as officer: Chief Medical Officer. This Jamil Khurram insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Galectin Therapeutics Inc. (GALT). Investors use Jamil Khurram's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Galectin Therapeutics Inc.GALT$0568 sharesSellMay 26, 2026$1.8K568 shares$3.10--
Galectin Therapeutics Inc.GALT$699568 sharesGrant / ExerciseMay 26, 2026$699568 shares$1.23--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Galectin Therapeutics Inc.GALT$198k65k sharesGrant / ExerciseJan 16, 2026$197.6K65k shares$3.04--
Galectin Therapeutics Inc.GALT--100k sharesGrant / ExerciseJan 16, 2026Disclosure amount unavailable100k shares----
Galectin Therapeutics Inc.GALT$021.4k sharesSellJan 6, 2026$78.2K21.4k shares$3.65--
Galectin Therapeutics Inc.GALT$84k21.4k sharesSellJan 5, 2026$99.4K25.5k shares$3.90--
Galectin Therapeutics Inc.GALT--60k sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable60k shares----
Galectin Therapeutics Inc.GALT$197k46.9k sharesSellJan 2, 2026$54.8K13.1k shares$4.20--
Galectin Therapeutics Inc.GALT--60k sharesGrant / ExerciseJan 1, 2026Disclosure amount unavailable60k shares----
Galectin Therapeutics Inc.GALT$08.1k sharesSellDec 31, 2025$33.1K8.1k shares$4.07--
Galectin Therapeutics Inc.GALT$10.0k8.1k sharesGrant / ExerciseDec 31, 2025$10.0K8.1k shares$1.23--
Galectin Therapeutics Inc.GALT$08.5k sharesSellDec 17, 2025$59.8K8.5k shares$7.04--
Galectin Therapeutics Inc.GALT$21k8.5k sharesGrant / ExerciseDec 17, 2025$21.3K8.5k shares$2.50--
Galectin Therapeutics Inc.GALT$14k6.5k sharesGrant / ExerciseDec 17, 2025$14.2K6.5k shares$2.20--
Galectin Therapeutics Inc.GALT$25k4.5k sharesSellNov 13, 2025$227.0K41.5k shares$5.47--
Galectin Therapeutics Inc.GALT$115k46k sharesGrant / ExerciseNov 13, 2025$103.8K41.5k shares$2.50--
Galectin Therapeutics Inc.GALT$101k46k sharesGrant / ExerciseNov 13, 2025$91.3K41.5k shares$2.20--
Galectin Therapeutics Inc.GALT$25k4.5k sharesSellNov 13, 2025$88.9K16.3k shares$5.47--
Galectin Therapeutics Inc.GALT$25k20.7k sharesGrant / ExerciseNov 13, 2025$20.0K16.3k shares$1.23--
Galectin Therapeutics Inc.GALT--60k sharesGrant / ExerciseJan 23, 2025Disclosure amount unavailable60k shares----
Galectin Therapeutics Inc.GALT$80k65k sharesGrant / ExerciseJan 23, 2025$80.0K65k shares$1.23--
Galectin Therapeutics Inc.GALT--40k sharesGrant / ExerciseDec 23, 2024Disclosure amount unavailable40k shares----
Galectin Therapeutics Inc.GALT$23k26.3k sharesSellDec 23, 2024$12.0K13.7k shares$0.8821--
Galectin Therapeutics Inc.GALT$250k100k sharesGrant / ExerciseAug 1, 2024$250.0K100k shares$2.50--
Galectin Therapeutics Inc.GALT--10k sharesGrant / ExerciseAug 1, 2024Disclosure amount unavailable10k shares----